Table 2.
| Cryoglobulin type | Content | Related diseases | Laboratory findings |
| Type I | Monoclonal immunoglobulins (IgG, IgM or IgA) or Bence Jones protein/monoclonal free light chains | Multiple Myeloma | Precipitation within 24 h Hyperviscosity |
| Waldenstrom Macroglobulinemia | |||
| Lymphoproliferative disease related monoclonal gammopathy | |||
| Light chain disease | |||
| Type II (mixed) | Monoclonal immunoglobulins (IgG, IgM or IgA) and polyclonal immunoglobulins (usually IgG) | HCV | Precipitation within 7 d HCV positivity Decreased C3 Decreased C4 Decreased CH50 Increased autoantibodies such as ANA, ENA, AMA |
| Essential cryoglobulinemia | |||
| Sjogren’s syndrome | |||
| Rheumatoid arthritis | |||
| Chronic lymphocytic leukemia | |||
| Type III (mixed) | Polyclonal immunoglobulins | Essential cryoglobulinemia | |
| Sjogren’s syndrome | |||
| Systemic lupus erythematosus | |||
| Viral infections (HBV, CMV, EBV, HIV) | |||
| Endocarditis | |||
| Biliary cirrhosis |
Type I cryoglobulin concentrations are > 5 g/L, so that they tend to precipitate within 1 d; whereas in mixed cryoglobulinemia, development of precipitation can take a couple of days[2]. After the precipitation is observed samples should be incubated at 37 °C again and dissolution of the precipitates at this temperature should be confirmed. If the precipitates do not dissolve at 37 °C, test should be reported to be negative. HBV: Hepatitis B virus; CMV: Cytomegalovirus; EBV: Epstein-Barr virus; ANA: Antinuclear antibodies; ENA: Extractable nuclear antigen antibodies; AMA: Antimitochondrial antibodies; HIV: Human immunodeficiency virus.